Mirela Ungureanu
Family Medicine · Trafalgar, INNPI 1225240377
Payments from drug & device makers
Across 119 payments — averaging $18.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$423
- Novartis$388
- Lilly USA, LLC$245
- AstraZeneca$126
- Ironshore Pharmaceuticals Inc.$99
- Amgen$88
- plus $823 from 25 others
What the payments were for
- Food & beverage$2,192100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 25 | $423 |
| Novartis | 13 | $388 |
| Lilly USA, LLC | 16 | $245 |
| AstraZeneca | 8 | $126 |
| Ironshore Pharmaceuticals Inc. | 4 | $99 |
| Amgen | 5 | $88 |
| Pfizer | 6 | $85 |
| Exact Sciences | 4 | $83 |
| GSK | 5 | $73 |
| Dexcom, Inc. | 2 | $51 |
| Merck | 3 | $45 |
| Sanofi Pasteur Inc. | 3 | $43 |
| Boehringer Ingelheim | 2 | $39 |
| AbbVie | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Verona Pharma, Inc. | 1 | $31 |
| Corium, LLC | 2 | $30 |
| Sanofi-aventis U.S. LLC | 2 | $27 |
| Cranial Technologies, Inc | 2 | $26 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Alkermes, Inc. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Bayer | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $12 |
| Sarepta Therapeutics, Inc. | 1 | $12 |
How this compares
$2,192 in reported general payments places this provider in the 70th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 208 | $245,998 |
| OzempicSemaglutide | 158 | $170,109 |
| JardianceEmpagliflozin | 42 | $69,402 |
| FarxigaDapagliflozin Propanediol | 73 | $66,801 |
| TrulicityDulaglutide | 51 | $56,957 |
| Tresiba Flextouch U-200Insulin Degludec | 33 | $27,945 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $20,665 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $13,897 |
| Spiriva RespimatTiotropium Bromide | 18 | $13,080 |
| VascepaIcosapent Ethyl | 14 | $10,727 |
| NeuproRotigotine | 12 | $9,949 |
| MyrbetriqMirabegron | 11 | $8,486 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 12 | $6,641 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 26 | $5,701 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 15 | $4,499 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $245 | $302,955259 claims |
| Novo NordiskOzempic | $423 | $170,109158 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Stiolto Respimat | $39 | $89,12372 claims |
| AstraZenecaFarxiga | $126 | $66,80173 claims |
| GSKTrelegy Ellipta, Shingrix | $73 | $19,59842 claims |
| AbbVieSynthroid | $37 | $1,51813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Trafalgar
- Blair BrengleIndianapolis$10.6M
- Laura HelmanMishawaka$4M
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
- Steven SmithIndianapolis$2.5M
- Renee Michelle GalenNewburgh$2.1M
- Eric HewittAvon$1.7M
- Alexander Dela LlanaEvansville$1.6M
- Jonathan ConditMuncie$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.